Veterinary Medicines and Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510244724

Publication Date:

October 29, 2024

Pages:

107

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

In this report, we study veterinary Medicines and Vaccines
The global market for Veterinary Medicines and Vaccines was estimated to be worth US$ 31680 million in 2023 and is forecast to a readjusted size of US$ 45660 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Medicines and Vaccines, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary Medicines and Vaccines by region & country, by Type, and by Application.
The Veterinary Medicines and Vaccines market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Medicines and Vaccines.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type:
Medicines
Vaccines
Segment by Application
Companion Animals
Farm Animals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Medicines and Vaccines manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Veterinary Medicines and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Veterinary Medicines and Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Veterinary Medicines and Vaccines Product Introduction
1.2 Global Veterinary Medicines and Vaccines Market Size Forecast
1.3 Veterinary Medicines and Vaccines Market Trends & Drivers
1.3.1 Veterinary Medicines and Vaccines Industry Trends
1.3.2 Veterinary Medicines and Vaccines Market Drivers & Opportunity
1.3.3 Veterinary Medicines and Vaccines Market Challenges
1.3.4 Veterinary Medicines and Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Medicines and Vaccines Players Revenue Ranking (2023)
2.2 Global Veterinary Medicines and Vaccines Revenue by Company (2019-2024)
2.3 Key Companies Veterinary Medicines and Vaccines Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary Medicines and Vaccines Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary Medicines and Vaccines
2.6 Veterinary Medicines and Vaccines Market Competitive Analysis
2.6.1 Veterinary Medicines and Vaccines Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary Medicines and Vaccines Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Medicines and Vaccines as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Medicines
3.1.2 Vaccines
3.2 Global Veterinary Medicines and Vaccines Sales Value by Type
3.2.1 Global Veterinary Medicines and Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Medicines and Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Medicines and Vaccines Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Companion Animals
4.1.2 Farm Animals
4.2 Global Veterinary Medicines and Vaccines Sales Value by Application
4.2.1 Global Veterinary Medicines and Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Medicines and Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Medicines and Vaccines Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Medicines and Vaccines Sales Value by Region
5.1.1 Global Veterinary Medicines and Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Medicines and Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Medicines and Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Medicines and Vaccines Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary Medicines and Vaccines Sales Value, 2019-2030
5.2.2 North America Veterinary Medicines and Vaccines Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary Medicines and Vaccines Sales Value, 2019-2030
5.3.2 Europe Veterinary Medicines and Vaccines Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary Medicines and Vaccines Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary Medicines and Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary Medicines and Vaccines Sales Value, 2019-2030
5.5.2 South America Veterinary Medicines and Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary Medicines and Vaccines Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary Medicines and Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Medicines and Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Medicines and Vaccines Sales Value
6.3 United States
6.3.1 United States Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.3.2 United States Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.4.2 Europe Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.5.2 China Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.6.2 Japan Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.7.2 South Korea Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Medicines and Vaccines Sales Value, 2019-2030
6.9.2 India Veterinary Medicines and Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Medicines and Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis Veterinary Medicines and Vaccines Products, Services and Solutions
7.1.4 Zoetis Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Profile
7.2.2 Boehringer Ingelheim Main Business
7.2.3 Boehringer Ingelheim Veterinary Medicines and Vaccines Products, Services and Solutions
7.2.4 Boehringer Ingelheim Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Merck Animal Health
7.3.1 Merck Animal Health Profile
7.3.2 Merck Animal Health Main Business
7.3.3 Merck Animal Health Veterinary Medicines and Vaccines Products, Services and Solutions
7.3.4 Merck Animal Health Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.3.5 Elanco Animal Health Recent Developments
7.4 Elanco Animal Health
7.4.1 Elanco Animal Health Profile
7.4.2 Elanco Animal Health Main Business
7.4.3 Elanco Animal Health Veterinary Medicines and Vaccines Products, Services and Solutions
7.4.4 Elanco Animal Health Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.4.5 Elanco Animal Health Recent Developments
7.5 Bayer Animal Health
7.5.1 Bayer Animal Health Profile
7.5.2 Bayer Animal Health Main Business
7.5.3 Bayer Animal Health Veterinary Medicines and Vaccines Products, Services and Solutions
7.5.4 Bayer Animal Health Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.5.5 Bayer Animal Health Recent Developments
7.6 Virbac
7.6.1 Virbac Profile
7.6.2 Virbac Main Business
7.6.3 Virbac Veterinary Medicines and Vaccines Products, Services and Solutions
7.6.4 Virbac Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.6.5 Virbac Recent Developments
7.7 Dechra Veterinary Products
7.7.1 Dechra Veterinary Products Profile
7.7.2 Dechra Veterinary Products Main Business
7.7.3 Dechra Veterinary Products Veterinary Medicines and Vaccines Products, Services and Solutions
7.7.4 Dechra Veterinary Products Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.7.5 Dechra Veterinary Products Recent Developments
7.8 Ceva
7.8.1 Ceva Profile
7.8.2 Ceva Main Business
7.8.3 Ceva Veterinary Medicines and Vaccines Products, Services and Solutions
7.8.4 Ceva Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.8.5 Ceva Recent Developments
7.9 Vetoquinol
7.9.1 Vetoquinol Profile
7.9.2 Vetoquinol Main Business
7.9.3 Vetoquinol Veterinary Medicines and Vaccines Products, Services and Solutions
7.9.4 Vetoquinol Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.9.5 Vetoquinol Recent Developments
7.10 Meiji
7.10.1 Meiji Profile
7.10.2 Meiji Main Business
7.10.3 Meiji Veterinary Medicines and Vaccines Products, Services and Solutions
7.10.4 Meiji Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.10.5 Meiji Recent Developments
7.11 Ouro Fino Saude
7.11.1 Ouro Fino Saude Profile
7.11.2 Ouro Fino Saude Main Business
7.11.3 Ouro Fino Saude Veterinary Medicines and Vaccines Products, Services and Solutions
7.11.4 Ouro Fino Saude Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.11.5 Ouro Fino Saude Recent Developments
7.12 Parnell
7.12.1 Parnell Profile
7.12.2 Parnell Main Business
7.12.3 Parnell Veterinary Medicines and Vaccines Products, Services and Solutions
7.12.4 Parnell Veterinary Medicines and Vaccines Revenue (US$ Million) & (2019-2024)
7.12.5 Parnell Recent Developments
8 Industry Chain Analysis
8.1 Veterinary Medicines and Vaccines Industrial Chain
8.2 Veterinary Medicines and Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Medicines and Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Medicines and Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂